Condition
Neonatal Anemia
Total Trials
5
Recruiting
0
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Completed4
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06285604Active Not RecruitingPrimary
Effect Evaluation of Different Blood Products Infusion on Neonatal Anemia
NCT00731588Phase 2CompletedPrimary
Red Blood Cell (RBC) Survival Following Transfusion in Infants
NCT02075970Phase 2CompletedPrimary
Optimized Erythropoietin (EPO) Treatment
NCT02454101Not ApplicableCompletedPrimary
Milking Versus Delayed Cord Clamping in Full Term Neonates
NCT01232387Completed
Identification of Early Predictors of Fetomaternal Hemorrhage
Showing all 5 trials